A bill prohibiting most employers in New York City from requiring drug tests for marijuana as a condition of employment was enacted last week—and it became law without the signature of Mayor Bill de Blasio (D), despite the fact that he previously pledged to put his name on the legislation.
The new law, sponsored by the city’s public advocate, Jumaane Williams (D), was approved by the City Council in a 40 to 4 vote last month. It was one of several cannabis-related reform bills on the table before the body.
De Blasio came out in support of marijuana legalization in December, just two days after Gov. Andrew Cuomo (D) announced that his position on the issue had also shifted to endorsing an end to cannabis prohibition. In a letter outlining his new stance, the mayor emphasized that equity in the marijuana industry should be an essential component of a legal market.
But while Williams’s bill is expected to contribute to that equity by ensuring that cannabis consumers face less discrimination in the workplace, de Blasio allowed the legislation to be enacted without signing it himself. His decision not to sign doesn’t necessarily mean he opposes the bill—indeed, he didn’t veto it—but it at least raises questions about how closely he’s following the reform movement happening in his own city at a time when he is reportedly seriously considering running for president.
When asked about the legislation in a radio interview last month, de Blasio said, “I will sign that bill.”
“I think that bill was absolutely right, because they made the right exceptions too,” he said. “And I think it’s part of how we change our culture to be less punitive and exclusionary. I think it’s a healthy step.”
His office also issued a supportive tweet at the time.
Marijuana laws have been used to keep people of color in prisons and out of the job market. New York City can become the Fairest Big City in America, but first we need to right the wrongs of the past War on Drugs.https://t.co/ADKzzr7LTH
— NYC Mayor's Office (@NYCMayorsOffice) April 13, 2019
It is unclear what changed in the intervening weeks.
Marijuana Moment reached out to de Blasio’s office for comment, but a representative was not immediately available.
Text of the legislation states that “[e]xcept as otherwise provided by law, it shall be an unlawful discriminatory practice for an employer, labor organization, employment agency, or agent thereof to require a prospective employee to submit to testing for the presence of any tetrahydrocannabinols or marijuana in such prospective employee’s system as a condition of employment.”
There are exceptions to the rule for “safety and security sensitive jobs” such as police officers, as well as “those tied to a federal or state contract or grant.” The new law will take effect in May 2020.
“It’s clear that we cannot wait until legalization on the state level before moving to reduce the impact that marijuana prohibition has had on individuals and communities,” Williams said in a press release. “Testing isn’t a deterrent to using marijuana, it’s an impediment to opportunity that dates back to the Reagan era—a war on drugs measure that’s now a war on workers. We need to be creating more access points for employment, not less—and if prospective employers aren’t testing for past alcohol usage, marijuana should be no different.”
We can’t wait until legalization in Albany before moving to reduce the impact marijuana prohibition has on individuals & communities.
NYC’s ban on pre-employment THC testing is now enacted. I’m proud to be taking down this barrier to employment:
— Jumaane Williams (@JumaaneWilliams) May 13, 2019
“While New York State deliberates and the federal government continues to prop up stigma and harmful policies, New York City must lead the way on this issue,” he said.
As de Blasio considers a run for the 2020 Democratic presidential nomination, which he said he’ll make a decision on this week, his record on cannabis policy will be scrutinized by drug reform advocates, some of whom suspect that his evolution on legalization was politically motivated after years of opposition. Inaction on certain reform legislation such as Williams’s bill will likely raise eyebrows.
Virtually every Democrat now in the race—with a major exception in former Vice President Joe Biden—now supports legalizing cannabis.
Meanwhile, statewide marijuana legalization legislation remains in flux in New York, with Cuomo expressing doubts that a bill will be passed this year following an unsuccessful attempt to include it in the budget. That said, a spokesperson for Assembly Speaker Carl Heastie (D) told the New York Post this week that the chamber is still “having thorough discussions of the proposal and are not aware of what the governor is talking about.”
Photo courtesy of Philip Steffan.
Senate Schedules Hearing On Marijuana Business Banking Access
In one of the clearest signs of marijuana reform’s growing momentum on Capitol Hill, a Republican-controlled Senate committee has scheduled a hearing for next week that will examine cannabis businesses’ lack of access to banking services.
The formal discussion in the Senate Committee on Banking, Housing and Urban Affairs on Tuesday comes as legislation aimed at resolving the marijuana industry’s financial services problems is gaining momentum. A House cannabis banking bill that cleared that chamber’s Financial Services Committee with a bipartisan vote in March now has 206 cosponsors—nearly half the body—while companion Senate legislation has 32 out of 100 senators signed on.
(Marijuana Moment’s editor provides some content to Forbes via a temporary exclusive publishing license arrangement.)
Congressman Files Marijuana Bill After Leaving Republican Party
In one of his first legislative acts since leaving the Republican Party earlier this month amid a feud with the president, Rep. Justin Amash (I-MI) filed a bill on Monday that would let states set their own marijuana policies without federal interference.
If that sounds familiar, it’s because bipartisan legislation that would accomplish the same goal has already been filed this Congress.
But unlike the nearly identical Strengthening the Tenth Amendment Through Entrusting States (STATES) Act, Amash’s new bill excludes one provision that would require the Government Accountability Office (GAO) to study the effects of cannabis legalization on road safety and issue a report on its findings within a year of the law’s enactment.
That language states that the GAO must study “traffic crashes, fatalities, and injuries” in legal cannabis states, actions taken by those states to “address marihuana-impaired driving,” testing standards being used to detect impaired driving and federal initiatives “aiming to assist States that have legalized marihuana with traffic safety.”
Given Amash’s libertarian leanings, it stands to reason that he opposes spending government dollars to conduct the research and simply supports the broader states’ rights intent of the original legislation.
That would also put him at odds with social justice advocates who feel that the STATES Act itself doesn’t go far enough and are pushing for more comprehensive legislation that includes additional provisions addressing social equity and restorative justice for people harmed by drug law enforcement.
Members of the House Judiciary Crime, Terrorism and Homeland Security Subcommittee heard that debate play out during a historic hearing on ending federal marijuana prohibition last week.
A newly formed coalition of civil rights and drug reform organizations, including the ACLU, is also insisting on passing wide-ranging legislation to deschedule cannabis entirely that also invests in communities that have been disproportionately impacted by prohibition.
Amash is a long-standing critic of the war on drugs and earlier this year signed on as a cosponsor of a separate bill that would federally deschedule marijuana. Rep. Tulsi Gabbard (D-HI), a 2020 Democratic presidential candidate, filed that legislation, which is also silent on social equity provisions.
— Justin Amash (@justinamash) March 8, 2019
Gabbard also introduced a separate bill that would require the U.S. Department of Health and Human Services and other federal agencies to study the impacts of legalization. True to form, Amash declined to add his name to that measure as well.
Read the text of Amash’s new cannabis bill below:
Photo courtesy of Kyle Jaeger.
Berkeley City Council Considers Decriminalizing Psychedelics This Week
A resolution to decriminalize psilocybin and other psychedelics will go before a Berkeley, California City Council committee on Wednesday.
Decriminalize Nature, the group behind the measure, also led the charge to successfully get a measure decriminalizing entheogenic plants and fungi approved by the City Council in neighboring Oakland last month.
In Berkeley, the Public Safety Committee will discuss the proposal and can either decide to hold it for a future meeting or advance it to the full Council. The public is able to attend Wednesday’s special meeting and share their perspective on the resolution, but Decriminalize Nature stressed in a tweet that this “is a small meeting, so you do NOT need to attend.”
Is it time for #DecriminalizeNature #Berkeley? Agenda 4 at the public safety meeting this Wed. July 17, with the Decriminalize Nature team! This is a small meeting, so you do NOT need to attend. But if you live in Berkeley, write your City Council! https://t.co/gMSDkegMPU
— Decriminalize Nature (@DecrimNature) July 15, 2019
However, city residents are being encouraged to write to their Council members and urge them to vote in favor of the measure, which would codify that “no department, agency, board, commission, officer or employee of the city, including without limitation, Berkeley Police Department personnel, shall use any city funds or resources to assist in the enforcement of laws imposing criminal penalties for the use and possession of Entheogenic Plants by adults of at least 21 years of age.”
The resolution defines the covered substances as “plants and natural sources such as mushrooms, cacti, iboga containing plants and/or extracted combinations of plants similar to ayahuasca; and limited to those containing the following types of compounds: indoleamines, tryptamines, phenethylamines.”
Councilmembers Rigel Robinson and Cheryl Davila are sponsoring the resolution, which does not allow for commercial sales or manufacturing.
The lawmakers provided background information on the measure in a report to their colleagues and the mayor, describing the medical potential of various psychedelics as well as the success of decriminalization measures in Denver and Oakland.
“It is intended that this resolution empowers Berkeley residents to be able to grow their own entheogens, share them with their community, and choose the appropriate setting for their intentions instead of having to rely exclusively on the medical establishment, which is slow to adapt and difficult to navigate for many,” they wrote.
While efforts to eliminate criminal penalties associated with psilocybin and other psychedelics have so far centered in jurisdictions that have historically embraced marijuana legalization and broader drug reform, the conversation around decriminalizing psychedelics is spreading nationally.
Shortly after Oakland approved its measure, Decriminalize Nature received inquiries from activities in cities from across the country. The group has kept track of each city where organizers are pursuing decriminalization.
Nature lovers are organizing coast to coast (and Hawaii)! Is your city on the map? Connect to join with your local community, or if you have the motivation to propose a similar initiative in your city/town/county, let’s start growing! contact [email protected] #DNUSA pic.twitter.com/38UxLKK9RN
— Decriminalize Nature (@DecrimNature) July 2, 2019
On Monday, a conversation around changing laws governing psychedelics reared during a City Council meeting in Columbia, Missouri. One resident implored the body to take up a resolution to decriminalize the natural substances, pointing to their therapeutic benefits.
Councilmember Mike Trapp said that the student’s proposal should be considered and that a government advisory board on public health should provide input on the medical potential of psychedelics, describing it as “very promising.”